Infection difficile Community-Associated Clostridium Meta-Analysis of Antibiotics and the Risk of

[1]  N. Beeching,et al.  Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom , 2011, PloS one.

[2]  Philip M Polgreen,et al.  Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study , 2011, BMC infectious diseases.

[3]  G. Dumyati,et al.  Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Ashley J. Mayo,et al.  A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. , 2011, The American journal of medicine.

[5]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[6]  E. Kuijper,et al.  Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  M. Millar,et al.  Community Clostridium difficile , 2009, BMJ : British Medical Journal.

[8]  A. Barkun,et al.  Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection , 2008, Canadian Medical Association Journal.

[9]  M. Wilcox,et al.  A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.

[10]  Carlene A. Muto,et al.  Antimicrobial-associated risk factors for Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[12]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. , 2007, Annals of internal medicine.

[13]  J. Dorca,et al.  Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. , 2007, Archives of internal medicine.

[14]  J. Higgins,et al.  Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. , 2007, International journal of epidemiology.

[15]  M. Olsen,et al.  Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. , 2007, Archives of internal medicine.

[16]  D. Gerding,et al.  In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004 , 2007, Antimicrobial Agents and Chemotherapy.

[17]  A. Barkun,et al.  Antimicrobial Drugs and Community–acquired Clostridium difficile–associated Disease, UK , 2007, Emerging infectious diseases.

[18]  J. Weese,et al.  Clostridium difficile in Retail Ground Meat, Canada , 2007, Emerging infectious diseases.

[19]  D. Juurlink,et al.  Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  P. Rochon,et al.  Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease? , 2006, Antimicrobial Agents and Chemotherapy.

[21]  T. Åkerlund,et al.  Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital , 2006, Antimicrobial Agents and Chemotherapy.

[22]  C. Donskey,et al.  Effect of Antibiotic Treatment on Growth of and Toxin Production by Clostridium difficile in the Cecal Contents of Mice , 2005, Antimicrobial Agents and Chemotherapy.

[23]  John M Colford,et al.  Systematic reviews and meta-analyses: an illustrated, step-by-step guide. , 2004, The National medical journal of India.

[24]  M. Stevenson,et al.  Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. , 2003, The Journal of antimicrobial chemotherapy.

[25]  A. Stergachis,et al.  Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. , 2000, Clinical therapeutics.

[26]  A Agresti,et al.  On Logit Confidence Intervals for the Odds Ratio with Small Samples , 1999, Biometrics.

[27]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.

[28]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[29]  H. Davies,et al.  When can odds ratios mislead? , 1998, BMJ.

[30]  G. Smith,et al.  Meta-analysis Spurious precision? Meta-analysis of observational studies , 1998, BMJ.

[31]  J. Brazier,et al.  The distribution of Clostridium difficile in the environment of South Wales. , 1996, Journal of medical microbiology.

[32]  R. Platt,et al.  Epidemiology of community-acquired Clostridium difficile-associated diarrhea. , 1994, The Journal of infectious diseases.

[33]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.